|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Operating activities | |
| Loss and comprehensive loss for the year | |
| Adjustments for | |
| Depreciation | |
| Share-based payments | |
| Amortization of flow-through premium liability | |
| Foreign exchange (gain) loss | |
| Finance expense (income), net | |
| Changes in non-cash working capital | |
| Other receivables | |
| Prepaid expenses and deposits | |
| Accounts payable and accrued liabilities | |
| Cash used in operating activities | |
| Investing activities | |
| Purchase of short-term investment | |
| Maturity of short-term investment | |
| Purchases of property, plant and equipment | |
| Cash provided by (used in) investing activities | |
| Financing activities | |
| Proceeds from issuance of common shares, net of issuance costs | |
| Proceeds from exercise of warrants | |
| Proceeds from exercise of options | |
| Cash provided by financing activities | |
| Effect of exchange rate on changes in cash and cash equivalents | |
| Change in cash and cash equivalents | |
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation, Beginning Balance | |
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation, Ending Balance | |
| Supplemental cash flow information | |
| Cash interest income received | |
| Fair value reversal on exercise of options | |
| Finders' warrants issued | |
| Interest paid in cash | |
| Income tax paid in cash |
Loading...
